EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease

Trace Thome, Nicholas A Vugman, Lauren E Stone, Keon Wimberly, Salvatore T Scali, Terence E Ryan

JCI Insight · 22.05.2024 · 9 (10)

DOI: 10.1172/jci.insight.178372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCI Insight, online erschienen am 23.04.2024. Verfasst von Trace Thome und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Applied Physiology and Kinesiology and. Hauptthemen laut MEDLINE: Muscle, Skeletal, Oxidative Phosphorylation, Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Receptors, Aryl Hydrocarbon. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) causes accumulation of uremic metabolites that negatively affect skeletal muscle. Tryptophan-derived uremic metabolites are agonists of the aryl hydrocarbon receptor (AHR), which has been shown to be activated in CKD. This study investigated the role of the AHR in skeletal muscle pathology of CKD. Compared with controls with normal kidney function, AHR-dependent gene expression ( CYP1A1 and CYP1B1 ) was significantly upregulated in skeletal muscle of patients with CKD, and the magnitude of AHR activation was inversely correlated with mitochondrial respiration. In mice with CKD, muscle mitochondrial oxidative phosphorylation (OXPHOS) was markedly impaired and strongly correlated with the serum level of tryptophan-derived uremic metabolites and AHR activation. Muscle-specific deletion of the AHR substantially improved mitochondrial OXPHOS in male mice with the greatest uremic toxicity (CKD + probenecid) and abolished the relationship between uremic metabolites and OXPHOS. The uremic metabolite/AHR/mitochondrial axis in skeletal muscle was verified using muscle-specific AHR knockdown in C57BL/6J mice harboring a high-affinity AHR allele, as well as ectopic viral expression of constitutively active mutant AHR in mice with normal renal function. Notably, OXPHOS changes in AHR mKO mice were present only when mitochondria were fueled by carbohydrates. Further analyses revealed that AHR activation in mice led to significantly increased pyruvate dehydrogenase kinase 4 (Pdk4) expression and phosphorylation of pyruvate dehydrogenase enzyme. These findings establish a uremic metabolite/AHR/Pdk4 axis in skeletal muscle that governs mitochondrial deficits in carbohydrate oxidation during CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscle, SkeletalOxidative PhosphorylationPyruvate Dehydrogenase Acetyl-Transferring KinaseReceptors, Aryl HydrocarbonRenal Insufficiency, ChronicAnimalsFemaleHumansMaleMiceMiddle AgedBasic Helix-Loop-Helix ProteinsCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Disease Models, AnimalEnergy MetabolismMice, Inbred C57BLMice, KnockoutMitochondria, MuscleTryptophanUremia

Stichwörter der Autor:innen

Chronic kidney diseaseMitochondriaMuscle biologyNephrologySkeletal muscle

Substanzen

Basic Helix-Loop-Helix ProteinsCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1Pyruvate Dehydrogenase Acetyl-Transferring KinaseReceptors, Aryl HydrocarbonTryptophanAHR protein, humanAhr protein, mousePdk4 protein, mouse

Autor:innen und Institutionen

  • Department of Applied Physiology and Kinesiology and.
  • Division of Vascular Surgery and Endovascular Therapy, University of Florida, Gainesville, Florida, USA.
  • Malcom Randall VA Medical Center, Gainesville, Florida, USA.
  • Center for Exercise Science and.
  • Myology Institute, University of Florida, Gainesville, Florida, USA.

Förderung

  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIA NIH HHS
  • National Heart, Lung, and Blood Institute
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute on Aging

Zitieren

APA

Thome, T., Vugman, N. A., Stone, L. E., Wimberly, K., Scali, S. T., & Ryan, T. E. (2024). A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease. JCI Insight, 9(10). https://doi.org/10.1172/jci.insight.178372

Vancouver

Thome T, Vugman NA, Stone LE, Wimberly K, Scali ST, Ryan TE. A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease. JCI Insight. 2024;9(10). doi:10.1172/jci.insight.178372

BibTeX
@article{Thome2024,
  author = {Thome, Trace and Vugman, Nicholas A and Stone, Lauren E and Wimberly, Keon and Scali, Salvatore T and Ryan, Terence E},
  title = {A tryptophan-derived uremic metabolite/Ahr/Pdk4 axis governs skeletal muscle mitochondrial energetics in chronic kidney disease},
  journal = {JCI Insight},
  year = {2024},
  volume = {9},
  number = {10},
  doi = {10.1172/jci.insight.178372}
}
Kostenlos starten →